Ibopamine 2% eye drops in the treatment of patients with ocular hypotony after vitreoretinal surgery for retinal detachment or uveitis: results after six months of treatment

Not Applicable

Completed

• Conditions: Ocular hypotony following either vitreoretinal surgery or uveitis; Eye Diseases

• Registration Number: ISRCTN46178243
• Lead Sponsor: Rotterdam Eye Hospital (Oogziekenhuis Rotterdam) (The Netherlands)

Brief Summary

2012 results in https://pubmed.ncbi.nlm.nih.gov/21909052/ (added 12/04/2021)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-12-20
• Study Completion: 2006-03-01
• Last Update Posted: 26 April 2021

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 17

Inclusion Criteria

1. Hypotony (0-5 mm Hg)
2. Stable eye pressure for at least 4 months
3. No reaction of eye pressure to atropine and steroids
4. Continued steroid treatment during past six months
5. Status after vitreoretinal surgery or uveitis

Exclusion Criteria

1. Chronic heart failure
2. Hypotony caused by other factors than surgery or uveitis
3. Traction on corpus ciliare
4. Cyclodialysis

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<br> 1. Ocular pressure<br> 2. Vision<br>

Secondary Outcome Measures

Name	Time	Method
<br> 1. Position of silicone oil (after surgery)<br> 2. Patient?s comfort/pain five minutes after eye drops administration<br>